52 /100
HIGH RISK
Score updated Jul 14, 2026

PAVS — Paranovus Entertainment Technology Ltd. Dilution Risk Tracker

Track PAVS dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track PAVS — Get alerts when the score changes →

As of July 14, 2026, Paranovus Entertainment Technology Ltd. (PAVS) has a DilutionWatch DilutionScore of 52/100, rated HIGH dilution risk. Paranovus Entertainment Technology Ltd. has a market capitalization of $1.22M, 66.72M shares outstanding, 1 institutional holders tracked. Key dilution vectors include approximately 23 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
25
📊 Float Risk
95
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

Watch
Minor dilution signals detected
15%
🔄 Reverse Split 30%
• 50-day avg $1.70 approaching $1 threshold
🔔 Track PAVS — Get forecast alerts →

💹 Market Data

Market Cap$1.22M
Shares Outstanding66.72M
FloatN/A
Cash$5.21M
Debt$2.24M
Short InterestN/A

🏛 Institutional Holdings

1 institutional holders · 861 shares
#1 UBS Group AG 861 shares

📉 Short Interest

Short Interest68.9K
Days to Cover1.0
% of FloatN/A
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

13F-HR BENEFICIAL OWNERSHIP Dec 31, 2025
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for PAVS Shareholders

Paranovus Entertainment Technology Ltd. (PAVS) has a DilutionScore of 52/100, placing it in the High dilution risk tier. This score reflects at least one active dilution mechanism — a shelf registration, ATM program, outstanding warrants, or limited cash runway — that could materially increase the share count over the next 12–18 months. Score as of July 14, 2026, updated from SEC EDGAR data.

DilutionWatch's EDGAR monitoring for PAVS shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for PAVS in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for PAVS alongside comparable high-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track PAVS Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking PAVS — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for PAVS
📊 PAVS FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 PAVS Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.